TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike

This study demonstrates that the host protease TMPRSS2 impairs antibody recognition of the SARS-CoV-2 spike protein by inducing partial S1 shedding and conformational changes in the S2 subunit, thereby promoting a fusion-intermediate state that is less accessible to humoral immune responses.

The Gist

The Big Picture: A Sneaky Locksmith and a Broken Key

Imagine the SARS-CoV-2 virus is a burglar trying to break into a house (your cells). To get in, the burglar wears a special Master Key on their jacket called the Spike Protein.

Usually, your body's immune system acts like a security guard. It has a huge bag of Antibodies (like specialized handcuffs or nets) designed to grab onto that Master Key and stop the burglar before they can enter.

This new study discovered something surprising: The virus has a secret helper inside your own body called TMPRSS2. Think of TMPRSS2 not as a villain, but as a sneaky locksmith that the virus tricks into helping it.

Here is how the study breaks down the magic trick:

1. The "Shedding" Act (The Key Loses a Piece)

When the virus lands on a cell, TMPRSS2 (the locksmith) starts cutting the Master Key.

• The Cut: It snips off the top part of the key (called the S1 part).
• The Result: The top part falls off and floats away. This is bad news for the security guards (antibodies) because many of them were trained to grab that specific top part. Now that it's gone, those guards can't grab the key anymore.

2. The "Shape-Shifting" Act (The Key Changes Form)

But here is the really clever part. Even the antibodies that were supposed to grab the bottom part of the key (the S2 part) get confused.

• The Metaphor: Imagine the key was a rigid plastic toy. TMPRSS2 cuts it, and suddenly the remaining piece turns into a wobbly, flexible noodle.
• The Effect: The security guards (antibodies) try to grab the noodle, but it keeps twisting and turning. It's too slippery and changes shape too fast to be caught. The study found that antibodies targeting the bottom part of the key were the most confused by this shape-shifting.

3. The "Decoy" Strategy

Because TMPRSS2 cuts the key so aggressively, it creates a lot of floating "top pieces" (S1) in the air around the cell.

• The Analogy: It's like the burglar throwing handfuls of fake keys into the air. The security guards get distracted, trying to catch the floating fake pieces, while the real burglar (the virus) slips past them and enters the house.

4. The Twist: The Virus is Still Dangerous

You might think, "If the key is broken and the top is gone, the burglar can't open the door, right?"

• The Surprise: Actually, the opposite happens. The "noodle" shape of the remaining key is actually better at opening the door once it touches the lock (the ACE2 receptor).
• The Trade-off: The virus sacrifices being easily seen by antibodies in exchange for being better at fusing with the cell. It becomes a "ghost" that is hard to catch but very good at entering.

5. The Good News: The Virus Particles are Different

The study also looked at the actual virus particles floating in your blood (the "burglars" waiting to attack).

• The Finding: When the virus is floating freely, it doesn't have TMPRSS2 cutting its keys yet. It's still wearing its full, recognizable outfit.
• Why it matters: This means our vaccines and treatments that target the virus in the blood still work pretty well. The "sneaky locksmith" trick mostly happens after the virus has already attached to a cell, helping the virus hide from the immune system inside the infection site.

Summary: What Does This Mean for Us?

• The Virus is Smarter Than We Thought: It uses our own body's enzymes (TMPRSS2) to hide its most vulnerable spots from our immune system.
• The "S2" Antibodies are Vulnerable: Antibodies that target the bottom of the spike (which are usually very good at stopping different virus variants) are the ones getting tricked the most by this shape-shifting.
• New Therapeutic Ideas: Since TMPRSS2 is the one doing the trick, maybe we can use drugs to stop the locksmith from cutting the key. If we stop the cut, the key stays rigid, the security guards can grab it, and the virus gets caught.

In a nutshell: The virus hires a local locksmith (TMPRSS2) to chop off its disguise and twist its shape just as the police arrive. This makes the virus harder to catch, even though it makes the key look broken. Understanding this trick helps scientists design better "police tactics" (vaccines and drugs) to catch the burglar before it gets inside.

Technical Summary

1. Problem Statement

While the role of the transmembrane serine protease TMPRSS2 in SARS-CoV-2 entry (via cleavage of the Spike protein) is well-established, its impact on the humoral immune response remains poorly characterized. Specifically, it is unknown whether TMPRSS2-mediated processing of the Spike (S) protein alters its conformation in a way that allows infected cells to evade antibody recognition. This is critical because:

• Infected cells express S on their surface, making them targets for antibody-dependent cellular cytotoxicity (ADCC).
• Antibodies targeting the S2 subunit (which are often cross-reactive and protective) are crucial for broad immunity.
• Understanding how cellular proteases shape S antigenicity could reveal novel viral immune escape mechanisms beyond simple mutation.

2. Methodology

The authors employed a multi-faceted approach combining cell biology, virology, and structural immunology:

• Cell Models:
  • Transfection: HEK293T cells stably expressing SARS-CoV-2 Spike (D614G and BA.5 variants) were transfected with TMPRSS2 (wild-type and catalytically inactive S441A mutant).
  • Infection Models: Caco2 (human intestinal) and IGROV-1 (ovarian cancer) cells were infected with SARS-CoV-2 variants (D614G, XBB.1.5). Some models used endogenous TMPRSS2, while others used overexpression.
  • Physiological Model: Differentiated human nasal epithelial cells (hNEC-ALI) were used to mimic physiological TMPRSS2 levels.
• Antibody Panel: A comprehensive panel of 39 monoclonal antibodies (mAbs) targeting various Spike regions (RBD, NTD, S2, Fusion Peptide, HR2) was utilized, alongside immune sera from individuals with "hybrid immunity" (infection + vaccination).
• Assays:
  • Flow Cytometry: To quantify mAb and serum binding to S-expressing cells.
  • ELISA: To detect soluble S1 shedding in supernatants.
  • ACE2 Binding Assay: To measure receptor affinity.
  • Cell-Cell Fusion Assay: A GFP-split system to measure syncytia formation.
  • ADCC Assay: Using CD16-NFAT reporter Jurkat cells to measure antibody-mediated effector function.
  • Flow Virometry: To analyze antibody binding directly on viral particles (virions) produced in TMPRSS2+ vs. TMPRSS2- cells.
  • Inhibitors: Camostat (a TMPRSS2 inhibitor) was used to confirm protease dependence.

3. Key Contributions & Results

A. TMPRSS2 Impairs Antibody Binding to Cell-Surface Spike

• Observation: Expression of catalytically active TMPRSS2 significantly reduced the binding of anti-S mAbs to the surface of S-expressing cells (up to 73% reduction for some antibodies).
• Specificity: The effect was dependent on TMPRSS2 enzymatic activity (inactive S441A mutant had no effect) and was specific to Spike (MHC-I binding was unaffected).
• Relevance: This was observed across multiple cell types, including Caco2, IGROV-1, and physiologically relevant hNEC-ALI models. Treatment with Camostat reversed the effect, increasing antibody binding.

B. Epitope-Specific Sensitivity

• S2 Subunit Vulnerability: Antibodies targeting the S2 subunit (including the Fusion Peptide and HR2 regions) were the most sensitive to TMPRSS2-mediated evasion (average ~73% reduction).
• S1 Subunit: Anti-RBD and Anti-NTD antibodies were also affected but to a lesser extent (~36% reduction).
• Correlation: The degree of binding reduction correlated negatively with the initial binding intensity in the absence of TMPRSS2; antibodies with lower baseline affinity were more susceptible to the conformational changes induced by TMPRSS2.

C. Mechanism: Conformational Rearrangement and S1 Shedding

• S1 Shedding: TMPRSS2 expression led to increased levels of soluble S1 in the supernatant, indicating partial shedding of the S1 subunit.
• Conformational Change: Despite S1 shedding, surface levels of the remaining S2 were not drastically reduced. However, the binding of antibodies to linear S2 epitopes (e.g., HR2) was significantly impaired.
• ACE2 vs. Fusion: TMPRSS2 reduced the binding of soluble ACE2 to the cell surface (suggesting fewer functional receptors available) but increased cell-cell fusion efficiency. This suggests TMPRSS2 drives Spike into a "fusion intermediate" state that is fusogenic but less accessible to antibodies.

D. Impact on ADCC and Polyclonal Sera

• Serum Binding: TMPRSS2 reduced the binding of polyclonal sera from hybrid-immune individuals to infected cells by ~52%.
• ADCC Inhibition: Consequently, TMPRSS2 expression significantly impaired Antibody-Dependent Cellular Cytotoxicity (ADCC), reducing CD16 activation by ~30%. This suggests infected cells expressing TMPRSS2 are less efficiently cleared by the immune system.

E. Conservation and Viral Progeny

• Conservation: The ability to reduce antibody binding was conserved across SARS-CoV-2 variants (D614G to KP.3.1.1) and other coronaviruses (229E, RaTG13), though not all TMPRSS family members were equally effective.
• Viral Particles: Crucially, TMPRSS2 expression in infected cells had minimal impact on the antigenicity of released viral particles (virions). Flow virometry showed that antibodies bound to virions produced in TMPRSS2+ cells similarly to those in TMPRSS2- cells. This implies the immune evasion mechanism primarily targets cell-surface Spike (syncytia/infected cell clearance) rather than free virions.

4. Significance and Conclusion

• Novel Immune Evasion Mechanism: The study identifies a non-mutational mechanism of immune evasion where the host's own protease (TMPRSS2) remodels the viral Spike protein into a conformation that is less recognizable by antibodies, particularly those targeting the conserved S2 subunit.
• Protection of Infected Cells: By reducing ADCC and antibody binding to cell-surface Spike, TMPRSS2 may allow infected cells to persist longer, facilitating viral spread via syncytia formation.
• Therapeutic Implications:
  • The findings suggest that TMPRSS2 inhibitors (like Camostat) could potentially enhance the efficacy of antibody therapies by "unmasking" the Spike protein, making infected cells more visible to the immune system.
  • It highlights the importance of S2-targeting antibodies in vaccine design, as these are the most vulnerable to TMPRSS2-mediated evasion, yet they are critical for cross-variant protection.
• Distinction between Cell and Virus: The study clarifies that while TMPRSS2 alters the antigenicity of Spike on infected cells, it does not significantly alter the neutralization sensitivity of the released virus, distinguishing the roles of TMPRSS2 in cell-to-cell spread versus transmission.

In summary, TMPRSS2 acts as a "pro-viral" factor not only by facilitating entry but also by actively remodeling the Spike protein on the surface of infected cells to shield them from humoral immune surveillance.